Yimei Que
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- CAR-T cell therapy research
Papers in
- Hematology 10
- Acute Myeloid Leukemia Research 5
- Multiple Myeloma Research and Treatments 5
-
- Epigenetics and DNA Methylation 2
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
- Co-authors
- Dengju Li (6 shared papers)Min Xiao (5 shared papers)Menglei Xu (7 shared papers)Xiangmei Liu (1 shared paper)Baichuan Wang (1 shared paper)Lei Tan (1 shared paper)Xiangcheng Qing (1 shared paper)Yanli Zhao (1 shared paper)
In The Last Decade
Yimei Que
16 papers receiving 227 citations
Peers
Comparison fields: 5 of 46
- Hematology 84
- Oncology 73
- Genetics 23
- Immunology 37
- Molecular Biology 109
Countries citing papers authored by Yimei Que
This map shows the geographic impact of Yimei Que's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimei Que with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimei Que more than expected).
Fields of papers citing papers by Yimei Que
This network shows the impact of papers produced by Yimei Que. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimei Que. The network helps show where Yimei Que may publish in the future.
Co-authors
The 25 scholars most cited alongside Yimei Que, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 69 | |
| 2 | 2020 | 33 | |
| 3 | 2021 | 25 | |
| 4 | 2021 | 23 | |
| 5 | 2020 | 21 | |
| 6 | 2021 | 16 | |
| 7 | 2023 | 11 | |
| 8 | 2022 | 8 | |
| 9 | 2019 | 7 | |
| 10 | 2023 | 5 | |
| 11 | 2024 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 |
About Yimei Que
Yimei Que is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Biomedical Engineering, having authored 16 papers that have together received 229 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (5 papers), T-cell and B-cell Immunology (3 papers), Nanowire Synthesis and Applications (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Epigenetics and DNA Methylation (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Hematology (84 citations), Oncology (73 citations), Genetics (23 citations), Immunology (37 citations) and Molecular Biology (109 citations). Yimei Que has collaborated with scholars based in China and Singapore. Frequent co-authors include Dengju Li, Min Xiao, Menglei Xu, Xiangmei Liu, Baichuan Wang, Lei Tan, Xiangcheng Qing, Yanli Zhao, Zengwu Shao and Xiangyu Deng. Their work appears in journals such as Frontiers in Immunology, Journal of Translational Medicine, International Journal of Cardiology, BMC Cancer and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.